All care is provided by MCNZ-registered healthcare professionals
If you have kidney disease, consult your doctor before starting any new supplement
STEP UP: The New Frontier in Semaglutide Efficacy The most recent addition to the semaglutide evidence base is the STEP UP trial, published in The Lancet Diabetes & Endocrinology in September 2025
This peptide is shipped by vial in a powder dried form that is reconstituted using sterile water and then injected under the skin where is absorbed into the skin itself and spread throughout
16-OHE 2 is a potent ER agonist, capable of levels of cellular proliferation stimulation that near those obtained with E 2
GLP-1 slows gastric emptying, increases release of insulin when sugar (glucose) is present, suppresses glucagon secretion and therefore liver glucose output, stimulates glucose uptake into cells, and increases proliferation of the cells in the pancreas that make insulin, Rhodes told Healthline